Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation

Autor: Arquette, Matthew, Wasserman, Todd, Govindan, Ramaswamy, Garfield, David, Senzer, Neil, Gillenwater, Heidi, Socinski, Mark
Zdroj: In Seminars in Radiation Oncology 2002 12(1) Supplement 1:59-61
Databáze: ScienceDirect